Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Buy
77
FMS Quote, Financials, Valuation and Earnings
Last price:
$22.71
Seasonality move
:
1.91%
Day range:
$22.57 - $22.76
52-week range:
$17.93 - $24.31
Dividend yield:
2.83%
P/E ratio:
18.60x
P/S ratio:
0.64x
P/B ratio:
0.88x
Volume:
77.1K
Avg. volume:
267.8K
1-year change:
8.71%
Market cap:
$13.3B
Revenue:
$21.1B
EPS (TTM):
$1.22
Analysts' Opinion
-
Consensus RatingFresenius Medical Care AG has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $20.96, Fresenius Medical Care AG has an estimated upside of 3.39% from its current price of $22.71.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.97 representing 100% downside risk from its current price of $22.71.
Fair Value
-
According to the consensus of 3 analysts, Fresenius Medical Care AG has 3.39% upside to fair value with a price target of $20.96 per share.
FMS vs. S&P 500
-
Over the past 5 trading days, Fresenius Medical Care AG has underperformed the S&P 500 by -6.76% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Fresenius Medical Care AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Fresenius Medical Care AG revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Fresenius Medical Care AG reported revenues of $5.2B.
Earnings Growth
-
Fresenius Medical Care AG has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Fresenius Medical Care AG reported earnings per share of $0.40.
Enterprise value:
11.8B
EV / Invested capital:
0.78x
Price / LTM sales:
0.64x
EV / EBIT:
6.63x
EV / Revenue:
0.57x
PEG ratio (5yr expected):
0.37x
EV / Free cash flow:
5.60x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
5.37x
Gross Profit (TTM):
$5.2B
Return On Assets:
1.94%
Net Income Margin (TTM):
3.43%
Return On Equity:
4.37%
Return On Invested Capital:
3.22%
Operating Margin:
8.87%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $20.6B | $20.8B | $20.9B | $5.4B | $5.2B | |
| Gross Profit | $5.1B | $5.1B | $5.2B | $1.3B | $1.3B | |
| Operating Income | $1.7B | $1.4B | $1.8B | $327.7M | $464.1M | |
| EBITDA | $3.7B | $2.9B | $2.2B | $380M | $527.9M | |
| Diluted EPS | $1.41 | $0.82 | $1.22 | $0.16 | $0.40 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9.2B | $9.3B | $8.4B | $9.6B | $9B | |
| Total Assets | $38.8B | $39.2B | $37.7B | $37.7B | $36.3B | |
| Current Liabilities | $8.3B | $8.7B | $6.2B | $7B | $6.6B | |
| Total Liabilities | $23.9B | $23.6B | $21.3B | $21.4B | $19.8B | |
| Total Equity | $14.9B | $15.6B | $16.4B | $16.3B | $16.5B | |
| Total Debt | $9.9B | $10B | $8.6B | $9B | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2022-12-31 | 2023-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.9B | $2.3B | $2.8B | $706.4M | $766.4M | |
| Cash From Investing | -$1.4B | -$774.8M | -$589.2M | -$261.3M | $351.5M | |
| Cash From Financing | -$1.2B | -$1.7B | -- | -$197.2M | -$2B | |
| Free Cash Flow | $1.9B | $1.5B | $2.1B | $441.2M | $965.9M | |
FMS
Sector
Market Cap
$13.3B
$46.1M
Price % of 52-Week High
93.42%
46.02%
Dividend Yield
2.83%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
8.71%
-30.52%
Beta (5-Year)
0.939
0.772
Dividend yield:
2.83%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$23.11
200-day SMA
Buy
Level
$20.47
Bollinger Bands (100)
Buy
Level
19.29 - 22.41
Chaikin Money Flow
Buy
Level
64.2M
20-day SMA
Sell
Level
$23.24
Relative Strength Index (RSI14)
Sell
Level
49.02
ADX Line
Sell
Level
17.2
Williams %R
Buy
Level
-85.1064
50-day SMA
Buy
Level
$21.88
MACD (12, 26)
Buy
Level
0.26
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Sell
Level
-9.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5899)
Sell
CA Score
(Annual)
Level (-0.5359)
Buy
Beneish M-Score
(Annual)
Level (-2.7313)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.6092)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Stock Forecast FAQ
In the current month, FMS has received 0 Buy ratings 2 Hold ratings, and 1 Sell ratings. The FMS average analyst price target in the past 3 months is $20.96.
-
Where Will Fresenius Medical Care AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Fresenius Medical Care AG share price will rise to $20.96 per share over the next 12 months.
-
What Do Analysts Say About Fresenius Medical Care AG?
Analysts are divided on their view about Fresenius Medical Care AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Fresenius Medical Care AG is a Buy and believe this share price will drop from its current level to $31.53.
-
What Is Fresenius Medical Care AG's Price Target?
The price target for Fresenius Medical Care AG over the next 1-year time period is forecast to be $20.96 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is FMS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Fresenius Medical Care AG is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of FMS?
You can purchase shares of Fresenius Medical Care AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Fresenius Medical Care AG shares.
-
What Is The Fresenius Medical Care AG Share Price Today?
Fresenius Medical Care AG was last trading at $22.71 per share. This represents the most recent stock quote for Fresenius Medical Care AG. Yesterday, Fresenius Medical Care AG closed at $22.71 per share.
-
How To Buy Fresenius Medical Care AG Stock Online?
In order to purchase Fresenius Medical Care AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
